Top 15 medical and healthcare startups in Italy
Dec 31, 1969
|
Like
12
1
Funding: $206.3M
AAVantgarde Bio is a clinical-stage biotechnology company that develops retinal disease gene therapies. One of its drugs is intended at patients with Stargardt disease, a leading cause of vision loss in children and young adults. By delivering the full-length ABCA4 protein, AAVantgarde hopes that it can address the root cause of this eye condition. Another asset is for patients with retinitis pigmentosa associated with Usher syndrome - rare genetic disease that affects both hearing and vision. AAVantgarde says that its proprietary technology has demonstrated high transduction, protein expression and safety for both Stargardt and Usher 1B.
AAVantgarde Bio is a clinical-stage biotechnology company that develops retinal disease gene therapies. One of its drugs is intended at patients with Stargardt disease, a leading cause of vision loss in children and young adults. By delivering the full-length ABCA4 protein, AAVantgarde hopes that it can address the root cause of this eye condition. Another asset is for patients with retinitis pigmentosa associated with Usher syndrome - rare genetic disease that affects both hearing and vision. AAVantgarde says that its proprietary technology has demonstrated high transduction, protein expression and safety for both Stargardt and Usher 1B.
2
Funding: $209.8M
MMI (Medical Microinstruments Inc) is a developer of novel robotic solutions for unmet medical needs.
MMI (Medical Microinstruments Inc) is a developer of novel robotic solutions for unmet medical needs.
3
Funding: $209.8M
MMI is focused on advancing robotic technology for soft tissue open surgery with the world's smallest wristed instruments.
MMI is focused on advancing robotic technology for soft tissue open surgery with the world's smallest wristed instruments.
4
Funding: €39M
Enthera's mission is to find new therapeutic approaches to treat diabetes and related gastrointestinal complication (enteropathy), as well as other intestinal disorders sharing the same biological pathway.
Enthera's mission is to find new therapeutic approaches to treat diabetes and related gastrointestinal complication (enteropathy), as well as other intestinal disorders sharing the same biological pathway.
5
Funding: $35.6M
We design and develop the world's smallest and most accurate wearable devices for medical research and epilepsy management.
We design and develop the world's smallest and most accurate wearable devices for medical research and epilepsy management.
6
Funding: $6.9M
Clinically validated and beautifully designed digital medicine and digital therapeutic solutions (DTx)
Clinically validated and beautifully designed digital medicine and digital therapeutic solutions (DTx)
7
Funding: €2.2M
Euleria is a provider of digital rehabilitation devices and solutions for better recovery of patients.
Euleria is a provider of digital rehabilitation devices and solutions for better recovery of patients.
8
Funding: €1.5M
Chino.io is a GDPR and HIPAA compliant Backend and Database as a Service for health data and applications.
Chino.io is a GDPR and HIPAA compliant Backend and Database as a Service for health data and applications.
9
Funding: €1.3M
BrainDTech represents a disruptive approach to brain disease diagnosis because it detects a signal (MicroRNA in microvesicles) released by microglia years before any clinical manifestation
BrainDTech represents a disruptive approach to brain disease diagnosis because it detects a signal (MicroRNA in microvesicles) released by microglia years before any clinical manifestation
10
Sensoria developed a technology platform comprising novel textile sensors, cloud and mobile software that enable a wide range of remote patient monitoring applications
12
Anbition Srl is developing new molecules and technologies for treating or diagnosing angiogenesis-related diseases
13
MEDICAL-NOTE is a medical app and software company born in 2018 whose purpose is to simplify daily tasks for surgeons, optimize preoperative planning and minimize complications through digital solutions.
14
Takis main focus is the development of therapeutic cancer vaccines against tumor antigens which play a role in tumor development and maintenance.
15
Huvant is a phygital medical simulation platform that supports pre-operative planning and device validation using realistic pathological anatomies. Complex procedures involve a high level of uncertainty. Understanding in advance how a strategy or a device will perform in real-life conditions helps optimize clinical outcomes, timelines and patient safety. Huvant’s platform reduces this uncertainty by enabling clinicians and medical companies to simulate procedures and test devices before reaching the patient, within a controlled and realistic environment. Clinicians can explore access pathways, analyze critical structures (landmarks, volumes, etc.), and compare different operative strategies. This allows the entire team to align around a shared plan that is safer and more predictable.
★
See also:
